While a lot of my work is involved in interacting with thought leaders in the biotechnology and pharmaceutical field, not all of my work is limited to players in the therapeutics sector. I assist those who provide high net worth advisory services and executives in home offices with understanding the biotech industry, and positioning their clients to benefit from the current golden age of genomics. This experience allows me to think about your drug, device, or diagnostic developmental project. Because of the expense of this service, clients generally have at least $5m to invest in biotechnology individually or collectively.